Study Stopped
Lack of funding
rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers
TSM-1
Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) of Limbic Brain Circuitry in Stress Modulation in a Healthy Population
Lack of funding
TSM-1
Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) of Limbic Brain Circuitry in Stress Modulation in a Healthy Population
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
April 10, 2023
Actual (reported)Primary Completion
April 10, 2023
Actual (reported)Study Completion
April 10, 2023
Actual (reported)This study will be conducted with healthy male and female participants. Aim 1 will determine during sham repetitive transcranial magnetic stimulation (rTMS) how a drug stressor combination (yohimbine + hydrocortisone) relative to placebo alters : (1a) impulsivity; (1b) mood; and (1c) physiology. Aim 2 will determine whether active rTMS over the medial prefrontal cortex alters the effects of stress-exposure on (2a) decision-making, (2b) mood, and (2c) biomarkers of stress.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 10, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 24, 2019
Actual (reported)November 29, 2019
Actual (reported)April 10, 2023
Actual (reported)April 10, 2023
Actual (reported)April 10, 2023
Actual (reported)Color-Word Stroop Task
reaction time (msec) measure of cognitive interference
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Digit Span Task
number of digits recalled, measure of verbal working memory
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Wisconsin Card Sorting Task
number of correct items, measure of ability to shift set and assesses cognitive flexibility
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Monetary Incentive Delay Task
number of rewards received, measure of motivation
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Delay Discounting Task
rate of monetary discounting
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
placebo stressor is lactose, and sham rTMS is inactive figure of 8 coil
placebo stressor is lactose, and active rTMS is 1Hz stimulation over the medial prefrontal cortex
yohimbine 54mg + hydrocortisone 20mg oral
1 Hz mPFC rTMS
Mark K Greenwald, PhD
Wayne State University
0 participants (actual enrollment reported by the registry).
First Submitted
November 24, 2019
First Posted
November 29, 2019
Study Start
Beetroot Juice for Boosting Immunity During a Time of Stress.
Effort Choice Task
number of progressive ratio (PR) choices vs. fixed ratio (FR) choices
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Positive and Negative Affect Schedule (PANAS) positive affect
10-item questionnaire sub scale that measures positive affect
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Positive and Negative Affect Schedule (PANAS) negative affect
10-item questionnaire sub scale that measures negative affect
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
State-Trait Anxiety Inventory
questionnaire subscale that measures state anxiety
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Blood pressure
Blood pressure (mm Hg)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Heart rate
Heart rate (beats/min)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Saliva cortisol level
Saliva cortisol level (µg/mL)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Saliva alpha-amylase level
Saliva alpha-amylase level (U/mL)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Plasma prolactin level
Plasma prolactin level (pg/mL)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
Plasma BDNF level
Plasma brain derived neurotrophic factor level (pg/mL)
change from pre- to post-intervention in each of the 4 sessions (through study completion, about 1 month total)
active stressor is the combination of yohimbine 54mg + hydrocortisone 20mg, and sham rTMS is inactive figure of 8 coil
active stressor is the combination of yohimbine 54mg + hydrocortisone 20mg, and active rTMS is 1Hz stimulation over the medial prefrontal cortex
placebo stressor
sham mPFC rTMS
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
April 10, 2023
Actual (reported)Primary Completion
April 10, 2023
Actual (reported)Study Completion
April 10, 2023
Actual (reported)Last Updated
April 13, 2023
Record last verified: 2023-04
Full sharing plan is being developed.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: